Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).

about

Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China.

P2860

Q51246325-B5D306D9-B7E1-4AC7-AC84-B545CF3718DE

P2860

Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).

Item

http://www.wikidata.org/entity/Q48127172

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical risk scoring for pred ...... ome patients (NAFLD-MS score).

@en

Clinical risk scoring for pred ...... in metabolic syndrome patients

@nl

type

Item

label

Clinical risk scoring for pred ...... ome patients (NAFLD-MS score).

@en

Clinical risk scoring for pred ...... in metabolic syndrome patients

@nl

prefLabel

Clinical risk scoring for pred ...... ome patients (NAFLD-MS score).

@en

Clinical risk scoring for pred ...... in metabolic syndrome patients

@nl

P1476

Clinical risk scoring for pred ...... rome patients (NAFLD-MS score)

@en

P2093

Aphinya Charoensak

http://www.w3.org/2001/XMLSchema#string

Phunchai Charatcharoenwitthaya

http://www.w3.org/2001/XMLSchema#string

Piyaporn Apisarnthanarak

http://www.w3.org/2001/XMLSchema#string

Shada Kanchanasuwan

http://www.w3.org/2001/XMLSchema#string

P2860

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers

From NAFLD in clinical practice to answers from guidelines

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome

Nonalcoholic fatty liver disease: a systematic review

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

P304

1535-1543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.13413

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Surasak Saokaew

Nathorn Chaiyakunapruk

Pochamana Phisalprapa

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28294515

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).

about

P2860

P2860

Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921